ADD CONDITION

items per page

A and E Marathon Delay Serum

Last content change checked dailysee data sync status

Active ingredient
Benzocaine 7.5 mg/100 mL
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
November 11, 2025
Active ingredient
Benzocaine 7.5 mg/100 mL
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
November 11, 2025
Manufacturer
Phe Inc
Registration number
M017
NDC root
87068-181

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is designed to help reduce sexual over-sensitivity in men. It aims to provide relief for those who may experience discomfort or challenges related to heightened sensitivity during sexual activity. By addressing this issue, the drug can support a more comfortable and enjoyable experience.

Uses

If you're experiencing sexual over-sensitivity, this medication can help reduce that sensitivity in men. It's designed to provide relief and improve your overall experience.

Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) or other nonteratogenic effects associated with this medication. This makes it a safe option for those who need it.

Dosage and Administration

To use this medication effectively, you should apply a small amount to the head and shaft of the penis about 2 to 3 minutes before engaging in sexual activity. This timing helps ensure that the medication can work properly when you need it.

Please remember that this product is intended for adult use only and should not be sold or used by anyone under the age of 18. Always follow these guidelines to ensure safe and effective use.

What to Avoid

It's important to keep this medication out of reach of children to prevent any accidental ingestion. If an overdose occurs or if the medication is ingested by someone who shouldn't have it, please contact a Poison Control Center immediately for assistance.

While there are no specific contraindications, risks of abuse, misuse, or dependence associated with this medication, always use it responsibly and as directed. Your safety is a priority, so ensure you follow these guidelines closely.

Side Effects

Using this product may lead to a serious condition called methemoglobinemia, which reduces the amount of oxygen in your blood. This can happen even if you have used the product before. If you or a child in your care experiences symptoms such as pale, gray, or blue skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness, or fatigue, it is important to stop using the product and seek immediate medical attention.

Warnings and Precautions

Using this product may lead to a serious condition called methemoglobinemia, which reduces the amount of oxygen in your blood. This can happen even if you have used the product before. If you or a child in your care experiences symptoms such as pale, gray, or blue skin (known as cyanosis), headache, rapid heart rate, shortness of breath, dizziness, or fatigue, stop using the product immediately and seek emergency medical help.

It's crucial to be aware of these symptoms and act quickly. If you notice any of these signs, do not hesitate to call your doctor or go to the nearest emergency room. Your health and safety are the top priority, so please take these warnings seriously.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. If you suspect an overdose, it is important to be aware of potential signs, which may include unusual drowsiness, confusion, or difficulty breathing.

In the event of an overdose, you should seek immediate medical attention. Contact your healthcare provider or go to the nearest emergency room right away. Always keep medications out of reach of children and follow the prescribed dosage to prevent any risk of overdose.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that there is no information available about the safety or use of this medication during pregnancy. This means that there are no specific guidelines, dosage adjustments, or precautions outlined for pregnant individuals.

Given this lack of information, you should consult with your healthcare provider before using this medication. They can help you understand any potential risks and make informed decisions about your treatment options during pregnancy.

Lactation Use

If you are breastfeeding or planning to breastfeed, you can feel reassured that there are no specific warnings or recommendations regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. However, it's always a good idea to consult with your healthcare provider about any concerns you may have regarding your health and breastfeeding.

Pediatric Use

This medication is intended for adults only and should not be given to minors. It's important to keep it out of reach of children to prevent accidental ingestion. If a child accidentally takes this medication, contact a Poison Control Center immediately for guidance.

If you notice any concerning symptoms in yourself or a child in your care, such as pale, gray, or blue skin (known as cyanosis), headache, rapid heart rate, shortness of breath, dizziness, or unusual fatigue, stop using the medication and seek medical attention right away. Your child's safety is the top priority, so always be vigilant about any changes in their health.

Geriatric Use

It's important to note that this medication is intended for adults only and should not be used by anyone under the age of 18. If you are an older adult or a caregiver, please ensure that this medication is used appropriately and that minors do not have access to it. Always consult with a healthcare professional if you have any questions or concerns about its use.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not change based on renal impairment. However, it’s always best to discuss your individual situation with your healthcare provider, as they can offer personalized advice and monitor your health closely.

Make sure to keep your doctor informed about your kidney health, as they may need to adjust your treatment plan based on your overall condition and any other medications you may be taking.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help determine the best course of action based on your individual situation.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. Currently, there are no specific drug interactions or laboratory test interactions noted for this medication. However, every individual’s health situation is unique, and your provider can help ensure that your treatment plan is safe and effective for you. Always feel free to ask questions and share all the medications and supplements you are using to avoid any potential issues.

Storage and Handling

To ensure the best performance of your product, store it at a temperature between 20-25°C (68-77°F). This temperature range helps maintain the integrity and effectiveness of the device.

When handling the product, be sure to do so with clean hands and in a sterile field (a clean area free from germs) to prevent contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal of any components.

Additional Information

You should apply a small amount of the medication to the head and shaft of the penis 2-3 minutes before engaging in sexual activity. This timing helps ensure the medication is effective when you need it. There are no additional details available regarding laboratory tests, abuse potential, or patient counseling.

FAQ

What is the primary use of this drug?

This drug is used to reduce sexual over-sensitivity in men.

How should I apply this drug?

You should apply a small amount to the head and shaft of the penis 2-3 minutes before sex.

Who can use this drug?

This drug is for adults only and is not for sale to minors.

What should I do if I experience serious side effects?

Stop use and seek immediate medical attention if you or a child in your care develops symptoms like pale, gray, or blue colored skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness, or fatigue.

Are there any warnings associated with this drug?

Yes, the drug may cause methemoglobinemia, a serious condition that reduces the amount of oxygen carried in the blood.

Is there any information regarding use during pregnancy?

No specific information regarding use during pregnancy is provided in the insert.

How should I store this drug?

Store the drug at 20-25°C (68-77°F).

What should I do if a child accidentally ingests this drug?

Keep the drug out of reach of children and contact a Poison Control Center for accidental overdose or ingestion.

Packaging Info

Below are the non-prescription pack sizes of A and E Marathon Delay Serum (delay serum). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for A and E Marathon Delay Serum.
Details

Drug Information (PDF)

This file contains official product information for A and E Marathon Delay Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the reduction of sexual over-sensitivity in men.

There are no teratogenic or nonteratogenic effects associated with this medication.

Dosage and Administration

The recommended application involves administering a small amount of the product to the head and shaft of the penis. This should be performed 2 to 3 minutes prior to sexual activity.

This product is intended for use in adults only and is not approved for sale to individuals under the age of 18.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. It is essential to keep the product out of reach of children. In the event of accidental overdose or ingestion, contact a Poison Control Center immediately for assistance.

Warnings and Precautions

The use of this product carries a significant risk of methemoglobinemia, a serious condition characterized by an abnormal level of methemoglobin in the blood, which impairs the oxygen-carrying capacity. Healthcare professionals should be vigilant, as methemoglobinemia can occur even in patients who have previously used this product without incident.

Immediate medical attention is warranted if any of the following symptoms develop in the patient or a child under their care: pale, gray, or blue-colored skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, or fatigue and lack of energy. In such cases, it is imperative to discontinue use of the product and seek emergency medical assistance without delay.

Healthcare providers are advised to educate patients and caregivers about these potential symptoms and the importance of prompt action should they arise. Regular monitoring and assessment of patients using this product may be prudent to ensure early detection and management of any adverse effects.

Side Effects

The use of this product may lead to methemoglobinemia, a serious condition characterized by reduced oxygen transport in the blood. This adverse reaction can occur even in patients who have previously used the product without incident. It is crucial for patients and caregivers to be vigilant for symptoms indicative of methemoglobinemia, which include pale, gray, or blue-colored skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, and fatigue or lack of energy. In the event that any of these symptoms develop, immediate medical attention should be sought to ensure prompt treatment.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of A and E Marathon Delay Serum (delay serum). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for A and E Marathon Delay Serum.
Details

Pediatric Use

Pediatric patients are not the intended population for this medication, which is approved for adult use only. It is crucial to keep this product out of reach of children to prevent accidental ingestion. In the event of an overdose or accidental ingestion, it is imperative to contact a Poison Control Center immediately.

Healthcare professionals should advise caregivers to monitor for serious adverse reactions. Immediate medical attention should be sought if a child exhibits symptoms such as pale, gray, or blue-colored skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, or fatigue or lack of energy.

Geriatric Use

Elderly patients are defined as individuals aged 65 years and older. The product is intended for use in adults only and is not approved for sale to minors. Therefore, healthcare providers should ensure that the use of this product is limited to the appropriate adult population, taking into consideration the specific needs and potential vulnerabilities of geriatric patients.

It is essential for healthcare providers to monitor elderly patients closely for any adverse effects or complications that may arise from the use of this product, given the unique physiological changes that occur with aging. Additionally, while specific dosage adjustments for geriatric patients are not provided, clinicians should exercise caution and consider individual patient factors when determining the appropriate dosage and treatment regimen.

Pregnancy

There is no information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

It is crucial to document any instances of overdose and report them to the appropriate regulatory authorities to enhance the understanding of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize the potential risks associated with overdose or unintentional consumption. In the event of an accidental overdose or ingestion, patients should be instructed to contact a Poison Control Center immediately for guidance and assistance. This information is crucial for ensuring patient safety and promoting responsible use of the medication.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20-25°C (68-77°F) to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent exposure to extreme temperatures or environmental factors that may compromise the product's quality.

Additional Clinical Information

Patients are advised to apply a small amount of the medication to the head and shaft of the penis 2-3 minutes prior to sexual activity. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for A and E Marathon Delay Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for A and E Marathon Delay Serum, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.